Pasar al contenido principal

COMPRENDER Y MODULAR LA ARTERIALIZACION DURANTE EL DESARROLLO TISULAR Y EN LA ENFERMEDAD CARDIOVASCULAR

PID2020-120252RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III (F.S.P.)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

iSuRe-HadCre is an essential tool for effective conditional genetics

  • Garcia-Gonzalez, Irene|||0000-0001-8508-8344
  • Rocha, Susana F.
  • Hamidi, Anahita
  • Garcia-Ortega, Lourdes
  • Regano, Alvaro
  • Sanchez-Muñoz, Maria S.
  • Lytvyn, Mariya
  • Garcia-Cabero, Aroa
  • Roig-Soucase, Sergi|||0000-0002-6214-6799
  • Schoofs, Hans|||0000-0003-3429-912X
  • Castro, Marco
  • Sabata Perez, Helena|||0000-0003-0637-0638
  • Potente, Michael|||0000-0002-5689-0036
  • Graupera, Mariona|||0000-0003-4608-4185
  • Makinen, Taija|||0000-0002-9338-1257
  • Benedito, Rui|||0000-0003-2458-3055
Methods for modifying gene function at high spatiotemporal resolution in mice have revolutionized biomedical research, with Cre-loxP being the most widely used technology. However, the Cre-loxP technology has several drawbacks, including weak activity, leakiness, toxicity, and low reliability of existing Cre-reporters. This is mainly because different genes flanked by loxP sites (floxed) vary widely in their sensitivity to Cre-mediated recombination. Here, we report the generation, validation, and utility of iSuRe-HadCre, a new dual Cre-reporter and deleter mouse line that avoids these drawbacks. iSuRe-HadCre achieves this through a novel inducible dual-recombinase genetic cascade that ensures that cells expressing a fluorescent reporter had only transient Cre activity, that is nonetheless sufficient to effectively delete floxed genes. iSuRe-HadCre worked reliably in all cell types and for the 13 floxed genes tested. This new tool will enable the precise, efficient, and trustworthy analysis of gene function in entire mouse tissues or in single cells.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Cis inhibition of NOTCH1 through JAGGED1 sustains embryonic hematopoietic stem cell fate

  • Thambyrajah, Roshana
  • Maqueda, Maria
  • Neo, Wen Hao
  • Imbach, Kathleen
  • Guillén, Yolanda
  • Grases, Daniela
  • Fadlullah, Zaki
  • Gambera, Stefano
  • Matteini, Francesca
  • Wang, Xiaonan
  • Calero-Nieto, Fernando J.
  • Esteller, Manel
  • Florian, Maria Carolina
  • Porta-Pardo, Eduard
  • Benedito, Rui
  • Göttgens, Berthold
  • Lacaud, Georges
  • Espinosa Blay, Lluís
  • Bigas Salvans, Anna
Hematopoietic stem cells (HSCs) develop from the hemogenic endothelium (HE) in the aorta- gonads-and mesonephros (AGM) region and reside within Intra-aortic hematopoietic clusters (IAHC) along with hematopoietic progenitors (HPC). The signalling mechanisms that distinguish HSCs from HPCs are unknown. Notch signaling is essential for arterial specification, IAHC formation and HSC activity, but current studies on how Notch segregates these different fates are inconsistent. We now demonstrate that Notch activity is highest in a subset of, GFI1 + , HSC-primed HE cells, and is gradually lost with HSC maturation. We uncover that the HSC phenotype is maintained due to increasing levels of NOTCH1 and JAG1 interactions on the surface of the same cell (cis) that renders the NOTCH1 receptor from being activated. Forced activation of the NOTCH1 receptor in IAHC activates a hematopoietic differentiation program. Our results indicate that NOTCH1-JAG1 cis-inhibition preserves the HSC phenotype in the hematopoietic clusters of the embryonic aorta., We thank Sarah Bray and David Sprinzak for critical discussions about cis interactions. We thank Genentech for kindly gifting the anti-JAG1 and anti-NOTCH1 antibodies. We thank all members of Espinosa and Bigas laboratories for helpful discussions and technical support. All illustrations in the manuscript were created with BioRender.com. We also thank the animal facility, FACS facility, and genomic facility of the PRBB and CRUK Manchester Institute for their technical support. This work was funded by grants from SAF2016-75613-R and PID2019-104695RB-I00 from Agencia Estatal de Investigación (AEI) and SLT002/16/00299 from Department of Health, Generalitat de Cataluña and 2021 SGR 00039 from AGAUR, Generalitat de Catalunya. The work in the G.L. laboratory is supported by Blood Cancer UK (19014) and Cancer Research UK Manchester Institute Core Grant (C5759/A27412). The work in R.B. laboratory was supported by a grant from the Ministerio de Ciencia e Innovación (MCIN - PID2020-120252RB-I00). RT is a recipient of BP2016 (00021) and BP/MSCA 2018 (00034) fellowship programs from Generalitat de Catalunya/MSCA. E.P. is a recipient of RYC2019-026415-I. M.M. is a recipient of a grant from the Instituto Carlos III, grant number CA22/00011 (cofunded by the European Social Fund Plus, ESF+, and by the European Union).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Cis inhibition of NOTCH1 through JAGGED1 sustains embryonic hematopoietic stem cell fate

  • Thambyrajah, Roshana
  • Maqueda, Maria
  • Neo, Wen Hao
  • Imbach, Kathleen
  • Guillén, Yolanda
  • Grases, Daniela
  • Fadlullah, Zaki
  • Gambera, Stefano
  • Matteini, Francesca
  • Wang, Xiaonan
  • Calero-Nieto, Fernando J.
  • Esteller, Manel
  • Florian, Maria Carolina
  • Porta-Pardo, Eduard
  • Benedito, Rui
  • Göttgens, Berthold
  • Lacaud, Georges
  • Espinosa Blay, Lluís
  • Bigas Salvans, Anna
Hematopoietic stem cells (HSCs) develop from the hemogenic endothelium (HE) in the aorta- gonads-and mesonephros (AGM) region and reside within Intra-aortic hematopoietic clusters (IAHC) along with hematopoietic progenitors (HPC). The signalling mechanisms that distinguish HSCs from HPCs are unknown. Notch signaling is essential for arterial specification, IAHC formation and HSC activity, but current studies on how Notch segregates these different fates are inconsistent. We now demonstrate that Notch activity is highest in a subset of, GFI1 + , HSC-primed HE cells, and is gradually lost with HSC maturation. We uncover that the HSC phenotype is maintained due to increasing levels of NOTCH1 and JAG1 interactions on the surface of the same cell (cis) that renders the NOTCH1 receptor from being activated. Forced activation of the NOTCH1 receptor in IAHC activates a hematopoietic differentiation program. Our results indicate that NOTCH1-JAG1 cis-inhibition preserves the HSC phenotype in the hematopoietic clusters of the embryonic aorta., We thank Sarah Bray and David Sprinzak for critical discussions about cis interactions. We thank Genentech for kindly gifting the anti-JAG1 and anti-NOTCH1 antibodies. We thank all members of Espinosa and Bigas laboratories for helpful discussions and technical support. All illustrations in the manuscript were created with BioRender.com. We also thank the animal facility, FACS facility, and genomic facility of the PRBB and CRUK Manchester Institute for their technical support. This work was funded by grants from SAF2016-75613-R and PID2019-104695RB-I00 from Agencia Estatal de Investigación (AEI) and SLT002/16/00299 from Department of Health, Generalitat de Cataluña and 2021 SGR 00039 from AGAUR, Generalitat de Catalunya. The work in the G.L. laboratory is supported by Blood Cancer UK (19014) and Cancer Research UK Manchester Institute Core Grant (C5759/A27412). The work in R.B. laboratory was supported by a grant from the Ministerio de Ciencia e Innovación (MCIN - PID2020-120252RB-I00). RT is a recipient of BP2016 (00021) and BP/MSCA 2018 (00034) fellowship programs from Generalitat de Catalunya/MSCA. E.P. is a recipient of RYC2019-026415-I. M.M. is a recipient of a grant from the Instituto Carlos III, grant number CA22/00011 (cofunded by the European Social Fund Plus, ESF+, and by the European Union).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Cis inhibition of NOTCH1 through JAGGED1 sustains embryonic hematopoietic stem cell fate

  • Thambyrajah, Roshana|||0000-0002-3941-760X
  • Maqueda, Maria|||0000-0001-9304-1714
  • Neo, Wen Hao|||0000-0002-6827-3027
  • Imbach, Kathleen|||0000-0002-3861-7845
  • Guillén, Yolanda|||0000-0001-8673-6470
  • Grases Mendoza, Daniela|||0000-0002-5981-7248
  • Fadlullah, Zaki
  • Gambera, Stefano|||0000-0003-2998-8502
  • Matteini, Fernando
  • Wang, Xiaonan|||0000-0003-3759-778X
  • Calero-Nieto, Fernando|||0000-0003-3358-8253
  • Esteller, M.|||0000-0003-4490-6093
  • Florian, María Carolina
  • Porta-Pardo, Eduard|||0000-0001-7900-4239
  • Benedito, Rui|||0000-0003-2458-3055
  • Göttgens, Berthold|||0000-0001-6302-5705
  • Lacaud, Georges|||0000-0002-5630-2417
  • Espinosa, Lluis|||0000-0002-2897-4099
  • Bigas Salvans, Anna|||0000-0003-4801-6899
Hematopoietic stem cells (HSCs) develop from the hemogenic endothelium (HE) in the aorta- gonads-and mesonephros (AGM) region and reside within Intra-aortic hematopoietic clusters (IAHC) along with hematopoietic progenitors (HPC). The signalling mechanisms that distinguish HSCs from HPCs are unknown. Notch signaling is essential for arterial specification, IAHC formation and HSC activity, but current studies on how Notch segregates these different fates are inconsistent. We now demonstrate that Notch activity is highest in a subset of, GFI1 +, HSC-primed HE cells, and is gradually lost with HSC maturation. We uncover that the HSC phenotype is maintained due to increasing levels of NOTCH1 and JAG1 interactions on the surface of the same cell (cis) that renders the NOTCH1 receptor from being activated. Forced activation of the NOTCH1 receptor in IAHC activates a hematopoietic differentiation program. Our results indicate that NOTCH1-JAG1 cis-inhibition preserves the HSC phenotype in the hematopoietic clusters of the embryonic aorta.